Term Gallery logo

Significats de glucocorticosteroid en anglès

rus
глюкокортикоид
portuguès
glicocorticoides
espanyol
glucocorticosteroide
català
glucocorticoide
Wikidata

Class of corticosteroids.

        Termes relacionats
        glucocorticoide
        Sinònims
        Examples for "glucocorticoid"
        Examples for "glucocorticoid"
        1
        Objective: To determine the effectiveness of glucocorticoid treatment in children with croup.
        Pubmed
        2
        The results suggest that THS was stable following treatment with glucocorticoid therapy.
        Pubmed
        3
        The magnitude of this reduction was similar with treatment of either glucocorticoid.
        Pubmed
        4
        Only men without acute disease exacerbation or systemic glucocorticoid treatment were included.
        Pubmed
        5
        FKBP5 regulates the cortisol-binding affinity and nuclear translocation of the glucocorticoid receptor.
        Pubmed
        1
        In the present paper the fluorescence properties of C60-glucocorticoids were firstly investigated.
        Pubmed
        2
        We investigated whether cosyntropin testing predicts treatment response to glucocorticoids in CAP.
        Pubmed
        3
        All of the 5 patients in stage III accepted glucocorticoids after diagnosis.
        Pubmed
        4
        At the same time, the use of glucocorticoids was also very important.
        Pubmed
        5
        The response to traditional therapy such as glucocorticoids may also be compromised.
        Pubmed
        Ús de glucocorticosteroid en anglès
        1
        Iatrogenic osteoporosis is a very common secondary osteoporosis is found in patients treated with large dosage of glucocorticosteroid of long duration.
        Pubmed
        2
        The efficacy of a glucocorticosteroid-inducible promoter was assessed in controlling transgene expression following lentivirus-mediated gene transfer to ovine and human corneas.
        Pubmed
        3
        The duration of treatment of primary disease with glucocorticosteroid is 1 to 3.5 years, with the average of 1.56 years.
        Pubmed
        4
        At presentation, all patients except one had been inappropriately treated with glucocorticosteroid (insufficiently dosed or tapered too fast) for longer than 2 weeks.
        Pubmed
        5
        The mechanisms appear to involve effects at the cell membrane as well as nuclear actions mediated by intracellular mineralo- and glucocorticosteroid receptors (MR and GR).
        Pubmed
        6
        Topical glucocorticosteroid treatment abolished this increase in nasal symptoms and TAME activity (p less than 0.05 for all treatment alternatives).
        Pubmed
        7
        In the active treatment alternatives, the glucocorticosteroid treatment was started 48, 12 or 2 hours before or 2 hours after the initial allergen challenge.
        Pubmed
        8
        Conclusions: Transfersome may significantly improve the risk-benefit ratio of topically applied glucocorticosteroids.
        Pubmed
        9
        Glucocorticosteroids are the most common first-line treatment for ECRS with nasal polyps.
        Pubmed
        10
        Glucocorticosteroids are highly effective in controlling inflammation and the molecular mechanisms involved are now becoming clear.
        Pubmed
        11
        Glucocorticosteroid treatment may offer some benefits.
        Pubmed
        12
        This knowledge is useful for the further development of glucocorticosteroids with desirable action spectrum and with minimal side effects.
        Pubmed
        13
        The ability of glucocorticosteroids to inhibit tissue eosinophilia may be an important feature of their anti-inflammatory action in allergic diseases.
        Pubmed
        14
        Topical glucocorticosteroids were incorporated into nanocarrier-based formulations, to overcome side effects of conventional formulations and to achieve maximum skin deposition.
        Pubmed
        15
        However, if proteinuria does not decrease significantly within 3 months from the beginning of this treatment, administration of glucocorticosteroids is recommended.
        Pubmed
        16
        Aim: Topical glucocorticosteroids are administered to virtually every corneal transplant recipient, but irreversible immunological rejection remains the leading cause of graft failure.
        Pubmed